检验医学
檢驗醫學
검험의학
LABORATORY MEDICINE
2015年
5期
433-436
,共4页
彭颖斐%吴炯%郭玮%陈方俊%秦嘉倩%徐雯%潘柏申
彭穎斐%吳炯%郭瑋%陳方俊%秦嘉倩%徐雯%潘柏申
팽영비%오형%곽위%진방준%진가천%서문%반백신
肾上腺素%去甲肾上腺素%多巴胺%尿液%液相色谱-串联质谱
腎上腺素%去甲腎上腺素%多巴胺%尿液%液相色譜-串聯質譜
신상선소%거갑신상선소%다파알%뇨액%액상색보-천련질보
Epinephrine%Norepinephrine%Dopamine:Urine%Liquid chromatography-tandem mass spectrometry
目的:建立尿液儿茶酚胺[包括肾上腺素(E)、去甲肾上腺素(NE)和多巴胺(DA)]的液相色谱-串联质谱(LC-MS/MS)检测方法。方法以 E-d3、NE-d6和 DA-d4盐酸盐为内标,采用 WATERS ACQUITY UPLC? HSS T3色谱柱(2.1 mm ×100 mm,1.8μm)进行分离。流动相 A1为2‰甲酸水溶液,流动相 B1为甲醇(纯度为99.9%),流速为0.5 mL/min,按 A1∶B1=95∶5等度洗脱。采用电喷雾(ESI)正离子模式进行质谱分析。对方法的线性、准确度(回收率)、不精密度及最低检出限等进行性能验证。选取表面健康人群65名,建立 E、NE 和 DA 的参考区间。结果采用建立的 LC-MS/MS 检测尿液 E、NE 和 DA,保留时间分别为0.58、0.89和0.63 min,检测范围为0.50~800.00 ng/mL。 E、NE 和 DA 的加标平均回收率分别为97.95%、97.78%和101.03%,最低检出限分别为0.25、2.50和2.50 ng/mL。 E、NE 和 DA 的参考区间分别为5.4~25.8、28.5~73.1和269.1~420.5μg/24 h。结论建立的LC-MS/MS 方法能同时检测尿液中的 E、NE 和 DA,可为嗜铬细胞瘤的诊断提供可靠的信息。
目的:建立尿液兒茶酚胺[包括腎上腺素(E)、去甲腎上腺素(NE)和多巴胺(DA)]的液相色譜-串聯質譜(LC-MS/MS)檢測方法。方法以 E-d3、NE-d6和 DA-d4鹽痠鹽為內標,採用 WATERS ACQUITY UPLC? HSS T3色譜柱(2.1 mm ×100 mm,1.8μm)進行分離。流動相 A1為2‰甲痠水溶液,流動相 B1為甲醇(純度為99.9%),流速為0.5 mL/min,按 A1∶B1=95∶5等度洗脫。採用電噴霧(ESI)正離子模式進行質譜分析。對方法的線性、準確度(迴收率)、不精密度及最低檢齣限等進行性能驗證。選取錶麵健康人群65名,建立 E、NE 和 DA 的參攷區間。結果採用建立的 LC-MS/MS 檢測尿液 E、NE 和 DA,保留時間分彆為0.58、0.89和0.63 min,檢測範圍為0.50~800.00 ng/mL。 E、NE 和 DA 的加標平均迴收率分彆為97.95%、97.78%和101.03%,最低檢齣限分彆為0.25、2.50和2.50 ng/mL。 E、NE 和 DA 的參攷區間分彆為5.4~25.8、28.5~73.1和269.1~420.5μg/24 h。結論建立的LC-MS/MS 方法能同時檢測尿液中的 E、NE 和 DA,可為嗜鉻細胞瘤的診斷提供可靠的信息。
목적:건립뇨액인다분알[포괄신상선소(E)、거갑신상선소(NE)화다파알(DA)]적액상색보-천련질보(LC-MS/MS)검측방법。방법이 E-d3、NE-d6화 DA-d4염산염위내표,채용 WATERS ACQUITY UPLC? HSS T3색보주(2.1 mm ×100 mm,1.8μm)진행분리。류동상 A1위2‰갑산수용액,류동상 B1위갑순(순도위99.9%),류속위0.5 mL/min,안 A1∶B1=95∶5등도세탈。채용전분무(ESI)정리자모식진행질보분석。대방법적선성、준학도(회수솔)、불정밀도급최저검출한등진행성능험증。선취표면건강인군65명,건립 E、NE 화 DA 적삼고구간。결과채용건립적 LC-MS/MS 검측뇨액 E、NE 화 DA,보류시간분별위0.58、0.89화0.63 min,검측범위위0.50~800.00 ng/mL。 E、NE 화 DA 적가표평균회수솔분별위97.95%、97.78%화101.03%,최저검출한분별위0.25、2.50화2.50 ng/mL。 E、NE 화 DA 적삼고구간분별위5.4~25.8、28.5~73.1화269.1~420.5μg/24 h。결론건립적LC-MS/MS 방법능동시검측뇨액중적 E、NE 화 DA,가위기락세포류적진단제공가고적신식。
Objective To establish a liquid chromatography-tandem mass spectrometry ( LC-MS/MS) for the determination of urinary catecholamines, including epinephrine ( E), norepinephrine ( NE) and dopamine ( DA). Methods E, NE and DA were separated by WATERS ACQUITY UPLC? HSS T3 (2.1 mm ×100 mm,1.8 μm column) using E-d3, NE-d6 and DA-d4 as internal standards.The mobile phase consisted of 2‰ formic acid aqueous solution ( A1) and methyl alcohol ( B1, purity =99.9%).The flow rate of 0.50 mL/min was applied to the chromatographic column.Flow starting was performed with A1 ∶B1 =95 ∶5.Electrospray ionization ( ESI) was operated in positive ion mode.The LC-MS/MS was used, with linearity, accuracy (recovery rate), imprecision and lower limit of determination being evaluated.A total of 65 healthy subjects were enrolled, and the reference ranges for E, NE and DA were established.Results The retention times of E, NE and DA were 0.58, 0.89, 0.63 min, respectively.The determination range was from 0.50 ng/mL to 800.00 ng/mL.The mean recovery ranges were 97.95%, deter mination range 97.78% and 101.03%.The lower limits of determination for E, NE and DA were 0.25, 2.50 and 2.50 ng/mL.The reference ranges were 5.4-25.8 μg/24 h for E, 28.5-73.1 μg/24 h for NE and 269.1-420.5 μg/24 h for DA.Conclusions The LC-MS/MS for the simultaneous determination of E, NE and DA has been established and is suitable for clinical application.It can provide reliable information for the diagnosis of phaeochromocytoma.